Skip to content

Percutaneous Endoscopic Lumbar Discectomy for Axillar Herniation at L5/S1 Via Transforaminal Approach Versus Interlaminar Approach: A Prospective Clinical Trial

Percutaneous Endoscopic Lumbar Discectomy for Axillar Herniation at L5/S1 Via Transforaminal Approach Versus Interlaminar Approach: A Prospective Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020463
Enrollment
Unknown
Registered
2018-12-30
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axillar Herniation at L5/S1

Interventions

Group 1:percutaneous endoscopic transforaminal discectomy (PETD)
Group 2:percutaneous endoscopic interlaminar discectomy(PEID)

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) unilateral redicular leg pain; 2) L5-S1 disc herniation between the dura sac and the S1 nerve root showed by the magnetic resonance imaging (MRI); 3) failure of regular conservative treatment at least 3 months.

Exclusion criteria

Exclusion criteria: 1) not an axillar type confirmed during the surgery; 2) recurrent disc herniation; 3) lumbar instability,such as lumbar spondylolisthesis; 4) intervertebral disc inflammation or tuberculosis; 5) widely lumbar stenosis; 6) cauda equina syndrome.

Design outcomes

Primary

MeasureTime frame
oswestry disability index (ODI);visual analogue scale (VAS);C-arm fluoroscopy times;operation time;complications;age;sex;Body Mass Index (BMI);axillar herniation size;

Countries

China

Contacts

Public ContactJie Hao

The First Affiliated Hospital of Chongqing Medical University

hjie2005@aliyun.com+86 13996120738

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026